We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$6.24B
AUM Growth
+$139M
Cap. Flow
+$46.3M
Cap. Flow %
0.74%
Top 10 Hldgs %
26.92%
Holding
404
New
21
Increased
154
Reduced
178
Closed
12

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$55.6M
2
OKE icon
Oneok
OKE
+$38.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$38.1M
4
MCD icon
McDonald's
MCD
+$33.4M
5
T icon
AT&T
T
+$30.5M

Sector Composition

Rank Sector Weight
1 Healthcare 16.35%
2 Technology 14.89%
3 Consumer Staples 14.37%
4 Industrials 12.52%
5 Energy 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCPC
126
Balchem Corp
BCPC
$5.7B
$3.83M 0.06%
73,455
-1,565
-2% -$84K
DEO icon
127
Diageo
DEO
$49.2B
$3.72M 0.06%
29,827
-1,577
-5% -$197K
PDCO
128
DELISTED
Patterson Companies, Inc.
PDCO
$3.57M 0.06%
85,454
+2,049
+2% +$83.7K
PSX icon
129
Phillips 66
PSX
$81.2B
$3.56M 0.06%
46,223
-4,203
-8% -$320K
GWW icon
130
W.W. Grainger
GWW
$60.7B
$3.38M 0.05%
13,388
+3
+0% +$749
ISRG icon
131
Intuitive Surgical
ISRG
$133B
$3.38M 0.05%
69,525
-6,120
-8% -$288K
HUB.B
132
DELISTED
HUBBELL INC CL-B
HUB.B
$3.36M 0.05%
28,040
SYY icon
133
Sysco
SYY
$40.3B
$3.3M 0.05%
91,459
-7,896
-8% -$284K
HDV
134
iShares Core High Dividend ETF
HDV
$14.8B
$3.29M 0.05%
229,940
-146,200
-39% -$2.03M
LLY icon
135
Eli Lilly
LLY
$1.04T
$3.21M 0.05%
54,598
-924
-2% -$51.6K
CL icon
136
Colgate-Palmolive
CL
$74.4B
$3.2M 0.05%
49,346
+1,722
+4% +$109K
SO icon
137
Southern Company
SO
$107B
$3.16M 0.05%
71,934
-11,096
-13% -$465K
XLK icon
138
State Street Technology Select Sector SPDR ETF
XLK
$122B
$3.13M 0.05%
172,180
+4,510
+3% +$80.5K
LOW icon
139
Lowe's Companies
LOW
$123B
$3.12M 0.05%
63,775
-5,917
-8% -$286K
EPP icon
140
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
$3.1M 0.05%
64,493
-1,800
-3% -$83K
CLX icon
141
Clorox
CLX
$12.8B
$3.04M 0.05%
34,586
+666
+2% +$58.5K
BRK.A icon
142
Berkshire Hathaway Class A
BRK.A
$1.12T
$3M 0.05%
16
-3
-16% -$527K
SAP icon
143
SAP
SAP
$228B
$2.94M 0.05%
36,150
-1,785
-5% -$142K
STE icon
144
Steris
STE
$22.7B
$2.89M 0.05%
60,472
+323
+0.5% +$15.1K
PFE icon
145
Pfizer
PFE
$147B
$2.85M 0.05%
93,422
+492
+0.5% +$14.7K
CRR
146
DELISTED
Carbo Ceramics Inc.
CRR
$2.84M 0.05%
20,580
-1,530
-7% -$181K
KMP
147
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$2.82M 0.05%
38,148
-6,260
-14% -$486K
EFA icon
148
iShares MSCI EAFE ETF
EFA
$79.4B
$2.8M 0.04%
41,667
+3,869
+10% +$256K
KN icon
149
Knowles
KN
$3.38B
$2.77M 0.04%
+87,648
New +$2.72M
MON
150
DELISTED
Monsanto Co
MON
$2.67M 0.04%
23,433
-165
-0.7% -$18.4K

Similar funds

Bahl & Gaynor's Q1 2014 Portfolio in Review

As of Q1 2014, Bahl & Gaynor held 404 positions worth $6.24B, up 2.3% from $6.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q1 2014 filing shows 21 new, 154 increased, 178 reduced and 12 closed positions. Its largest new stake was Cencora: 276,922 shares worth $18.2M. The largest sale was Intel, an estimated $55.6M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.

  • Bahl & Gaynor's largest Q1 2014 buy was Cencora: 276,922 shares worth $18.2M.
  • Bahl & Gaynor added most to 3M in Q1 2014, an estimated $83M increase.
  • Bahl & Gaynor's biggest Q1 2014 reduction was Intel, cutting an estimated $55.6M.
  • Bahl & Gaynor fully exited Atrion Corp in Q1 2014, selling an estimated $478K.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $6.24B portfolio in Q1 2014.
  • Bahl & Gaynor opened 21 new positions and closed 12 in Q1 2014.
  • Bahl & Gaynor's portfolio value rose 2.3% quarter-over-quarter to $6.24B.

Based on Bahl & Gaynor's 13F filing for Q1 2014, filed 20 May 2014.